These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The synergic effect of BRAF Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763 [TBL] [Abstract][Full Text] [Related]
4. Ultrasound validation of predictive model for central cervical lymph node metastasis in papillary thyroid cancer on Chen J; Li XL; Zhang YF; Wang D; Wang Q; Zhao CK; Li MX; Wei Q; Ji G; Xu HX Future Oncol; 2020 Aug; 16(22):1607-1618. PubMed ID: 32501726 [No Abstract] [Full Text] [Related]
6. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Howell GM; Nikiforova MN; Carty SE; Armstrong MJ; Hodak SP; Stang MT; McCoy KL; Nikiforov YE; Yip L Ann Surg Oncol; 2013 Jan; 20(1):47-52. PubMed ID: 22941165 [TBL] [Abstract][Full Text] [Related]
7. Predicting factors of central lymph node metastasis and BRAF Zhou SL; Guo YP; Zhang L; Deng T; Xu ZG; Ding C; Sun WC; Zhao YW; Kong LF World J Surg Oncol; 2021 Jul; 19(1):211. PubMed ID: 34256769 [TBL] [Abstract][Full Text] [Related]
8. Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0). Gao X; Luo W; He L; Cheng J; Yang L Front Endocrinol (Lausanne); 2021; 12():789310. PubMed ID: 35154002 [TBL] [Abstract][Full Text] [Related]
9. Suspicious ultrasound characteristics correlate with multiple factors that predict central lymph node metastasis of papillary thyroid carcinoma: Significant role of HBME-1. Jianming L; Jibin L; Linxue Q Eur J Radiol; 2020 Feb; 123():108801. PubMed ID: 31918249 [TBL] [Abstract][Full Text] [Related]
10. Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers. Han PA; Kim HS; Cho S; Fazeli R; Najafian A; Khawaja H; McAlexander M; Dy B; Sorensen M; Aronova A; Sebo TJ; Giordano TJ; Fahey TJ; Thompson GB; Gauger PG; Somervell H; Bishop JA; Eshleman JR; Schneider EB; Witwer KW; Umbricht CB; Zeiger MA Thyroid; 2016 Apr; 26(4):532-42. PubMed ID: 26950846 [TBL] [Abstract][Full Text] [Related]
11. Correlation between US-FNAC with BRAF V600E Mutation Analysis and Central Neck Lymph Node Metastasis in cN0 Papillary Thyroid Cancer. Li R; Hao J; Zhu Z; Qiao X; Wang L; Zhou Z Biomed Res Int; 2021; 2021():9937742. PubMed ID: 34307677 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study. Du J; Yang Q; Sun Y; Shi P; Xu H; Chen X; Dong T; Shi W; Wang Y; Song Z; Shang X; Tian X Front Endocrinol (Lausanne); 2023; 14():1288527. PubMed ID: 38047112 [TBL] [Abstract][Full Text] [Related]
13. An Online Model for Central Lymph Node Metastases in Papillary Thyroid Carcinoma With BRAF V600E Mutation. Chen H; Pan WK; Ren SY; Zhou YL Am J Clin Oncol; 2024 Aug; 47(8):383-390. PubMed ID: 38664891 [TBL] [Abstract][Full Text] [Related]
14. A prediction model incorporating the BRAF Liu S; Liu C; Zhao L; Wang K; Li S; Tian Y; Jiao B; Gui Z; Yu T; Zhang L Eur J Surg Oncol; 2021 Nov; 47(11):2774-2780. PubMed ID: 34483032 [TBL] [Abstract][Full Text] [Related]
15. The role of BRAF(V600E) mutation as poor prognostic factor for the outcome of patients with intrathyroid papillary thyroid carcinoma. Pelizzo MR; Dobrinja C; Casal Ide E; Zane M; Lora O; Toniato A; Mian C; Barollo S; Izuzquiza M; Guerrini J; De Manzini N; Merante Boschin I; Rubello D Biomed Pharmacother; 2014 May; 68(4):413-7. PubMed ID: 24721322 [TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer With BRAF V600E Mutation. Han Y; Hou L; Zhao B; Gao L; Li S Front Endocrinol (Lausanne); 2022; 13():884428. PubMed ID: 35784548 [TBL] [Abstract][Full Text] [Related]
17. BRAF V600E mutation: Differential impact on central lymph node metastasis by tumor size in papillary thyroid carcinoma. Kim SK; Lee JH; Woo JW; Park I; Choe JH; Kim JH; Kim JS Head Neck; 2016 Apr; 38 Suppl 1():E1203-9. PubMed ID: 26268700 [TBL] [Abstract][Full Text] [Related]
18. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study. Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785 [TBL] [Abstract][Full Text] [Related]
19. Value of Multimodal Ultrasound Combined with BRAF Gene in Evaluating Cervical Lymph Node Metastasis of Papillary Thyroid Microcarcinoma. Xue J; Qu N; Liu H; Bi M; Cao X Ultrasound Med Biol; 2024 Aug; 50(8):1183-1187. PubMed ID: 38704301 [TBL] [Abstract][Full Text] [Related]
20. Sonographic Characteristics of Papillary Thyroid Carcinoma With Coexistent Hashimoto's Thyroiditis in the Preoperative Prediction of Central Lymph Node Metastasis. Chen S; Niu C; Peng Q; Tang K Front Endocrinol (Lausanne); 2021; 12():556851. PubMed ID: 33796065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]